These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30482197)

  • 41. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
    Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Arterial Remodeling of Intermediate Coronary Lesions on Long-Term Clinical Outcomes in Patients with Stable Coronary Artery Disease: An Intravascular Ultrasound Study.
    Geng L; Du P; Yuan Y; Gao L; Wang Y; Li J; Zhang Q
    J Interv Cardiol; 2021; 2021():9915759. PubMed ID: 34220369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association of hemoglobin A1c and high risk plaque and plaque extent assessed by coronary computed tomography angiography.
    Tomizawa N; Inoh S; Nojo T; Nakamura S
    Int J Cardiovasc Imaging; 2016 Mar; 32(3):493-500. PubMed ID: 26463885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients.
    Peng WH; Lu L; Hu J; Yan XX; Zhang Q; Zhang RY; Chen QJ; Shen WF
    Clin Biochem; 2009 Aug; 42(12):1252-9. PubMed ID: 19439163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study.
    Kim SH; Moon JY; Lim YM; Kim KH; Yang WI; Sung JH; Yoo SM; Kim IJ; Lim SW; Cha DH; Cho SY
    Cardiovasc Diabetol; 2015 Jun; 14():74. PubMed ID: 26047939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%.
    Hirose M; Kobayashi Y; Mintz GS; Moussa I; Mehran R; Lansky AJ; Dangas G; Kreps EM; Collins MB; Stone GW; Colombo A; Leon MB; Moses JW
    Am J Cardiol; 2003 Jul; 92(2):141-5. PubMed ID: 12860214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
    von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
    Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carotid artery plaque and LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries in asymptomatic patients with type 2 diabetes mellitus.
    Fujihara K; Suzuki H; Sato A; Kodama S; Heianza Y; Saito K; Iwasaki H; Kobayashi K; Yatoh S; Takahashi A; Yamada N; Sone H; Shimano H
    J Atheroscler Thromb; 2013; 20(5):452-64. PubMed ID: 23363982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the albumin glycation site, plasma pentosidine and esRAGE concentrations before and after intensive diabetic treatment in patients with abnormally high glycated albumin levels.
    Miyamoto H; Kohzuma T; Ohnishi A
    Ann Clin Biochem; 2018 Jan; 55(1):84-91. PubMed ID: 28504612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
    Iwata A; Miura S; Tanaka T; Ike A; Sugihara M; Nishikawa H; Kawamura A; Saku K
    Coron Artery Dis; 2012 Aug; 23(5):315-21. PubMed ID: 22617341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxidized low-density lipoprotein and high-density lipoprotein cholesterol modulate coronary arterial remodeling: an intravascular ultrasound study.
    Yoneyama S; Arakawa K; Yonemura A; Isoda K; Nakamura H; Ohsuzu F
    Clin Cardiol; 2003 Jan; 26(1):31-5. PubMed ID: 12539810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between baseline plaque features and subsequent coronary artery remodeling determined by optical coherence tomography and intravascular ultrasound.
    Xie Z; Dong N; Sun R; Liu X; Gu X; Sun Y; Du H; Dai J; Liu Y; Hou J; Tian J; Yu B
    Oncotarget; 2017 Jan; 8(3):4234-4244. PubMed ID: 27992371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.
    Voros S; Joshi P; Qian Z; Rinehart S; Vazquez-Figueroa JG; Anderson H; Elashoff M; Murrieta L; Karmpaliotis D; Kalynych A; Brown C; Schaefer E; Asztalos B
    J Am Heart Assoc; 2013 Nov; 2(6):e000344. PubMed ID: 24252842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study.
    Jensen LO; Thayssen P; Mintz GS; Carlier SG; Pedersen KE; Haghfelt T
    Cardiology; 2006; 106(4):256-63. PubMed ID: 16710086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction: Incidence, Morphologic Characteristics, and Outcomes After Percutaneous Coronary Intervention.
    Higuma T; Soeda T; Abe N; Yamada M; Yokoyama H; Shibutani S; Vergallo R; Minami Y; Ong DS; Lee H; Okumura K; Jang IK
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1166-1176. PubMed ID: 26117464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
    Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-related effects of smoking on coronary artery disease assessed by gray scale and virtual histology intravascular ultrasound.
    Kang SJ; Mintz GS; Weisz G; Mehran R; Rabbani LE; Verheye S; Serruys PW; Xu K; Stone GW; Maehara A
    Am J Cardiol; 2015 Apr; 115(8):1056-62. PubMed ID: 25726380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.